Canadian Sec - Delayed Quote ? CAD Telescope Innovations Corp. (TELI.CN) Follow Compare 0.4500 +0.0500 (+12.50%) At close: October 18 at 3:59 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Telescope Innovations Becomes Certified Systems Integrator of Universal Robots Certification enables faster development and deployment of Telescope's Self-Driving Labs Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, announces its achievement of Certified Systems Integrator ("CSI") status for robotic instruments sold by Universal Robots ("UR"). UR has eme Newsfile ? 5 days ago TELIF Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines Telescope's proprietary ReCRFT process produces >99.5% pure lithium carbonate from Altillion's brine concentrates Vancouver, British Columbia--(Newsfile Corp. - September 17, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research engagement with Altillion, Inc. ("Altillion") an innovator Newsfile ? last month TELIF Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research collaboration with Standard Lithium Ltd. (TSXV: SLI) (NYSE American: SLI) ("Standard Lithium").Over the past year, Telescope Innovations and Standard Lithium have worked toget Newsfile ? last month TELIF SLI Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement Funding from and collaboration with Pfizer could facilitate Telescope's growth and R&D advancement Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the execution of a master collaborative research agreement (the "Agreement") with Pfizer Inc. ("Pfizer"). Under the multi- Newsfile ? 2 months ago TELIF Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy ("CICE"). This non-dilutive investment will support Telescope's piloting of its proprietary Recrystallization Refinement Technology ("ReCRFT?" Newsfile ? 2 months ago TELIF Telescope Innovations Presents Results of Third Fiscal Quarter 2024 Year-to-date revenues surpass entire fiscal year 2023 Vancouver, British Columbia--(Newsfile Corp. - July 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2024. The Company generated revenues of $1.2 million during this period (Q3, 2024). Telescope's corresponding fiscal year-to-da Newsfile ? 3 months ago TELIF Telescope Innovations Joins MaRS: North America's Largest Urban Innovation Hub Vancouver, British Columbia--(Newsfile Corp. - June 24, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been accepted as a member of MaRS Discovery District, ("MaRS") a network of the most promising and innovative young technology companies in Canada. As North America's largest urban innovation hub, MaRS empowers member companies to generate Newsfile ? 3 months ago TELIF Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024 Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation the 2024 Lithium Supply and Battery Raw Materials Conference hosted by Fastmarkets. The conference will take place on June 24-27 in Las Vegas, NV. Dr. Ryan Jansonius, VP of Chemistry Contract Services fo Newsfile ? 4 months ago TELIF Telescope Innovations to Showcase DirectInject-LC(TM) Product and Process IP at METTLER TOLEDO Events Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation in two "InfoDays" sponsored by METTLER TOLEDO. Telescope will feature two proprietary innovations during the New Jersey and Montreal InfoDays. InfoDays are high-profile industry and academia networking ev Newsfile ? 5 months ago TELIF Telescope Innovations Presents Results of Second Fiscal Quarter 2024 Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results and operational highlights for the fiscal quarter ended February 29, 2024. The Company generated revenues of $686,205 during this period, driven by strong sales performance of its flagship product, DirectInject-LC?. O Newsfile ? 5 months ago TELIF Telescope Innovations Develops Novel Battery Recycling Technology A new approach isolates lithium and valuable transition metals from battery recycling feeds Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is leading a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces Newsfile ? 6 months ago TELIF Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership Telescope pairs its DirectInject-LC(TM) technology with Shimadzu's chemical analysis instrumentation Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces that it is engaged in a technology integration partnership with Shimadzu Scientific Instruments, Inc. ("Shimadzu"). Shimadzu is a global leade Newsfile ? 7 months ago TELIF Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary Vancouver, British Columbia--(Newsfile Corp. - February 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to welcome Henry Dubina as Chairman and Chief Executive Officer and John Kirincic as Chief Financial Officer for the Company. Jason Hein will continue to lead Telescope's development services and research efforts as Chief Technology Officer, Newsfile ? 8 months ago TELIF Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope's Flagship Product, DirectInject-LC(TM) Vancouver, British Columbia--(Newsfile Corp. - February 5, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces it has signed a Distribution Agreement with METTLER TOLEDO (NYSE: MTD) for Telescope's online chemistry sampling and analysis product, the DirectInject-LC?. METTLER TOLEDO is a global leader of precision instruments and services, including auto Newsfile ? 8 months ago TELIF Telescope Innovations Presents Results of First Fiscal Quarter 2024 The Company exceeded its quarterly revenue and profit records in Q1, 2024 Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2023. The Company generated revenues of $1.50 M for a net income of $215,000 (Figure 1). Figure 1. Newsfile ? 8 months ago TELIF Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials A novel refinement process generates battery-quality lithium carbonate in a single step Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces it has fil Newsfile ? 8 months ago TELIF Telescope Innovations Reports Strong Growth in Fiscal Year 2023 Vancouver, British Columbia--(Newsfile Corp. - December 22, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal year ended August 31, 2023. The Company generated revenues of $2.82 M, representing an increase of 375% over the previous fiscal year.Figure 1. Revenue and net income chart for FY 2022 and 2023.To vi Newsfile ? 9 months ago TELIF Telescope Innovations Develops New IP for the Production of Battery Materials Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces it has filed a provisional patent application (65/584,062) on the production of lithium sulfide, a key precursor for next-generation solid-state batteries.As an outcome of work with Standard Lithium Ltd., Telescope has invented a Newsfile ? 9 months ago TELIF Telescope Innovations and Mott Corporation Initiate Technology Partnership The chem tech and precision filtration companies plan to develop a novel robotic sampling probe Vancouver, British Columbia--(Newsfile Corp. - October 30, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, announces that it has signed a Memorandum of Understanding ("MOU") partnership with Mott Corporation ("Mott"). Mott is a top technology-driven, precis Newsfile ? 11 months ago TELIF Performance Overview Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return TELI.CN S&P/TSX Composite index YTD +87.50% +18.44% 1-Year +83.67% +26.05% 3-Year +40.63% +17.71%
